시장보고서
상품코드
1462895

부인과 질환 관련 사업 협력 및 라이선스 거래(2016-2024년)

Gynecology Collaboration and Licensing Deals 2016-2024

발행일: | 리서치사: Current Partnering | 페이지 정보: 영문 100+ Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

본 보고서에서는 최근(2016-2024년) 부인과 질환 치료제 개발 관련 사업 협력 및 라이선스 거래의 거래 동향을 분석하여, 전체 거래 건수 추이, 재무적 측면(지불조건)의 경향, 주요 기업의 거래 형성 움직임, 계약 조건의 경향, 적응증별(치료 타겟별) 경향 등을 조사하고, 최근 주요 제휴 거래의 상세 정보를 정리하여 전해드립니다. 경향 등을 조사하고, 최근 주요 제휴 거래에 대한 상세 정보를 정리하여 전해드립니다.

목차

주요 요약

제1장 서론

제2장 부인과 질환 관련 거래 성립 경향

  • 서론
  • 부인과 질환 관련 거래 성립 : 장기적 동향
  • 부인과 질환 관련 거래 성립 : 거래 유형별
  • 부인과 질환 관련 거래 성립 : 업계별
  • 부인과 질환 관련 거래 성립 : 개발 단계별
  • 부인과 질환 관련 거래 성립 : 기술 유형별
  • 부인과 질환 관련 거래 성립 : 치료 대상 적응증별

제3장 부인과 질환 관련 사업 제휴 : 재무 측면 조건

  • 서론
  • 부인과 질환 관련 사업 제휴에 대한 재무 조건 공개
  • 부인과 질환 관련 사업 제휴 : 거래 총액
  • 부인과 질환 관련 사업 제휴 : 선불금
  • 부인과 질환 관련 사업 제휴 : 마일스톤 지불
  • 부인과 질환 관련 사업 제휴 : 로열티율

제4장 부인과 질환 관련 주요 거래처와 거래

  • 서론
  • 부인과 질환 관련 제휴로 가장 활동적인 기업
  • 부인과 질환 관련 가장 활동적인 기업 리스트
  • 부인과 질환 관련 주요 거래 : 계약금액별

제5장 부인과 질환 계약 문서 디렉토리

  • 서론
  • 부인과 질환 관련 자본거래 동향 : 계약 문장을 열람 가능한 거래의 경우

제6장 부인과 질환 관련 거래 성립 : 치료 표적별

  • 서론
  • 부인과 질환 관련 거래 성립 : 치료 표적별
  • 거래 리스트
  • 부인과 질환 관련 거래 리스트, 기업명별(ABC순, 2016-2024년)
  • 부인과 질환 관련 거래 리스트, 기술 유형별(2016-2024년)
  • 거래 유형 정의
  • Biopharma Research Ltd.에 대해
  • 현재 제휴
  • 현재 계약
  • Current Partnering의 최근 보고서 제목
LSH 24.04.30

Gynecology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gynecology deals entered into by the worlds leading biopharma companies.

Fully revised and updated, the report provides details of gynecology deals from 2016 to 2024.

The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of collaboration and licensing deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of gynecology dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in gynecology dealmaking.

Chapter 3 covers the financial deal terms for deals signed in the gynecology field with stage of development announced. Deals are listed and sectioned by headline value, upfront payment, milestone payment and royalty rates.

Chapter 4 provides a review of the top 25 most active biopharma companies in gynecology dealmaking. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive and detailed review of gynecology deals signed and announced since 2016 where a contract document is available. Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of gynecology deals listed by theraeutic target.

The report also includes numerous table and figures that illustrate the trends and activities in gynecology deal making since 2016.

In addition, a comprehensive deal directory is provided organized by company A-Z and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Key benefits

Gynecology Collaboration and Licensing Deals provides the reader with the following key benefits:

  • Understand deal trends since 2016
  • Browse gynecology collaboration and licensing deals
  • Benchmark analysis - identify market value of transactions
  • Financials terms - upfront, milestone, royalties
  • Directory of deals by company A-Z, therapy focus and technology type
  • Leading deals by value
  • Most active dealmakers
  • Identify assets and deal terms for each transaction
  • Access contract documents - insights into deal structures
  • Due diligence - assess suitability of your proposed deal terms for partner companies
  • Save hundreds of hours of research time

Report scope

  • Gynecology Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of gynecology trends and structure of deals entered into by leading biopharma companies worldwide.

Gynecology Collaboration and Licensing Deals includes:

  • Trends in gynecology dealmaking in the biopharma industry
  • Overview of collaboration and licensing deal structure
  • Directory of gynecology deal records covering pharmaceutical and biotechnology
  • The leading gynecology deals by value
  • Most active gynecology licensing dealmakers

In Gynecology Collaboration and Licensing Deals, the available deals are listed by:

  • Company A-Z
  • Headline value
  • Therapeutic area
  • Technology type
  • Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
  • Gynecology Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in gynecology dealmaking

  • 2.1. Introduction
  • 2.2. Gynecology partnering over the years
  • 2.3. Gynecology partnering by deal type
  • 2.4. Gynecology partnering by industry sector
  • 2.5. Gynecology partnering by stage of development
  • 2.6. Gynecology partnering by technology type
  • 2.7. Gynecology partnering by therapeutic indication

Chapter 3 - Financial deal terms for gynecology partnering

  • 3.1. Introduction
  • 3.2. Disclosed financials terms for gynecology partnering
  • 3.3. Gynecology partnering headline values
  • 3.4. Gynecology deal upfront payments
  • 3.5. Gynecology deal milestone payments
  • 3.6. Gynecology royalty rates

Chapter 4 - Leading gynecology deals and dealmakers

  • 4.1. Introduction
  • 4.2. Most active in gynecology partnering
  • 4.3. List of most active dealmakers in gynecology
  • 4.4. Top gynecology deals by value

Chapter 5 - Gynecology contract document directory

  • 5.1. Introduction
  • 5.2. Gynecology partnering deals where contract document available

Chapter 6 - Gynecology dealmaking by therapeutic target

  • 6.1. Introduction
  • 6.2. Deals by gynecology therapeutic target
  • Deal directory
  • Deal directory - Gynecology deals by company A-Z 2016 to 2024
  • Deal directory - Gynecology deals by technology type 2016 to 2024
  • Deal type definitions
  • About Biopharma Research Ltd
  • Current Partnering
  • Current Agreements
  • Recent report titles from Current Partnering

Table of figures

  • Figure 1: Gynecology partnering since 2016
  • Figure 2: Gynecology partnering by deal type since 2016
  • Figure 3: Gynecology partnering by industry sector since 2016
  • Figure 4: Gynecology partnering by stage of development since 2016
  • Figure 5: Gynecology partnering by technology type since 2016
  • Figure 6: Gynecology partnering by indication since 2016
  • Figure 7: Gynecology deals with a headline value
  • Figure 8: Gynecology deals with upfront payment values
  • Figure 9: Gynecology deals with milestone payment
  • Figure 10: Gynecology deals with royalty rates
  • Figure 11: Active gynecology dealmaking activity since 2016
  • Figure 12: Top gynecology deals by value since 2016
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제